Page last updated: 2024-09-04

alpha-ergocryptine and Pituitary Neoplasms

alpha-ergocryptine has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bancroft, C; Dong, KW; McChesney, R; Roberts, JL; Sealfon, SC; Tsutsumi, M	1

Other Studies

1 other study(ies) available for alpha-ergocryptine and Pituitary Neoplasms

Article	Year
Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter. Molecular and cellular endocrinology, 1991, Volume: 79, Issue:1-3 Topics: Animals; Cell Line; Ergolines; Female; Hysterectomy; Ovariectomy; Pituitary Neoplasms; Plasmids; Prolactin; Prolactinoma; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D1; RNA, Messenger; Signal Transduction; Spiperone; Transcription, Genetic	1991

Article

Year

Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter.

Molecular and cellular endocrinology, 1991, Volume: 79, Issue:1-3

Topics: Animals; Cell Line; Ergolines; Female; Hysterectomy; Ovariectomy; Pituitary Neoplasms; Plasmids; Prolactin; Prolactinoma; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D1; RNA, Messenger; Signal Transduction; Spiperone; Transcription, Genetic

1991